Hello new staff #8

Anna is from a small village outside of Skellefteå, a town in the north of Sweden and is studying the immune function of HIV-treated pregnant women and their children.

Chandrashekar comes from India, south India Bangalore city. He did his PhD at the University of Piemonte, Novara, Italy and has been working as post-doctoral researcher at Karolinska institutet the last 4,5 years.

Chandrashekar is currently working as a post doc in a project to develop Vaccine for SARS CoV2 in Prof Matti Sällberg Group. He has previous working experience in the project endocrine regulation of lymphoma growth with in vivo xenograft model and in vitro studies in Prof Sam Okret group.

Negin comes from Iran and will work in the Open Corona Project developing a vaccine that protects against SARS-CoV-2.

Jolly previously worked at Södertörns Högskola as Education Administrator. Her background is a degree in Social work and working in Social service. Now she's up for new adventures and challenges with assisting teachers and students with their work at the Division of Pathology.

Mikhail was born in Saint-Petersburg, Russia and previously comes from Uppsala University. He will investigate new methods to prevent and treat acute kidney injury.

Mohammad was born in Alexandria, Egypt in 1986 and had his bachelor’s degree from faculty of science, Alexandria University. In 2012, he got his master’s degree in Applied Medical Chemistry, Medical Research Institute, Alexandria University. He has been to Sweden since 2016, and performed his PhD at Sahlgrenska Academy, Gothenburg, Sweden. On 10th of January 2020, he defended his thesis and worked for short-term as a research assistant at the same university until 30th of June 2020.

On 19th of August, he started as a postdoctoral fellow at Birgitta Sander´s group, Karolinska Institute, Sweden. The main focus of his upcoming research line is to investigate the combined functions of the transcription factor Sox11, which is a molecular signature of clinically aggressive subtypes of mantle cell lymphoma in regulating response to nucleotides-based therapies and regulation of DNA damage as well.